Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A)
91396
Phase 2 small_molecule completed
Quick answer
Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A) for Magnetic Resonance Angiography is a Phase 2 program (small_molecule) at Bayer HealthCare AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer HealthCare AG
- Indication
- Magnetic Resonance Angiography
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed